West Virginia Pediatric Clinical Trials Network-2
西弗吉尼亚州儿科临床试验 Network-2
基本信息
- 批准号:10064509
- 负责人:
- 金额:$ 41.79万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-01 至 2025-08-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAcuteAddressAppalachian RegionBehavior TherapyCharacteristicsChildChild HealthChildhoodChronicChronic DiseaseClinicalClinical ResearchClinical SciencesClinical TrialsClinical Trials NetworkCollaborationsDiseaseEconomicsEffectivenessEnvironmental Risk FactorFacultyFosteringFundingGoalsHealthHuman ResourcesHypertensionInfantInfrastructureInstitutesInterventionInvestigationLeadLeadershipMentorsMethodsMissionMulticenter TrialsNeonatal Abstinence SyndromeOutcomePediatric ResearchPerformancePositioning AttributePreventionResearchResearch InfrastructureResearch PersonnelResourcesRural PopulationSiteStandardizationStructureTeacher Professional DevelopmentTrainingTranslational ResearchUnderserved PopulationUrsidae FamilyWest VirginiaWorkcatalystclinical research siteexperiencefollow-upin uteroinsightinterestneonateopioid epidemicopioid exposurepsychosocialrecruitruralityskillssuccesstooltrend
项目摘要
Abstract
West Virginia (WV) bears long-standing physical, psychosocial and fiscal characteristics, including the opioid
crisis, limited resources and a restricted economy, that have significantly impacted the health of its residents.
The West Virginia Pediatric Clinical Trials Network (WVPCTN), as a Clinical Site of the ECHO IDeA States PCTN
(ISPCTN), has catalyzed emerging solutions to address some of these burdens by fulfilling its mission.
Specifically, the mission of the WVPCTN has been two-fold - bringing clinical trials to our underserved population,
and building professional capacity for clinical research. Our WVU site has been well positioned to be a successful
Clinical Site due to a combination of structural and human resources that were already in place when the ISPCTN
was initiated in 2016, and the background and expertise of the three PIs – Drs. Saul, Pyles and Cottrell. The
addition of the funds and resources provided by ISPCTN led to an acceleration of WVUs capacity to actively
participate in clinical trials by allowing us to create a dedicated Pediatric Research Unit (PRU) and introduce a
group of junior, less experienced clinical trial investigators, into both ISPCTN and non-ISPCTN trials. The
effectiveness of this approach has been demonstrated through an increase in faculty participation in ISPCTN
activities, a strong recruitment record, and an increase in the number of non-ISPCTN Pediatric trials at WVU.
The WVPCTN is now actively growing an experienced investigator pool and a group of mentee investigators, all
enhanced by the resources and expertise of the West Virginia Clinical Translational Science Institute (WVCTSI).
These features and resources, together with strong and sustained partnerships throughout the state, and the
multiple environmentally related conditions of our citizens, continue to uniquely position us to be successful as
an ISPCTN Clinical Site and work to propose new trials for the network. This proposal for WVPCTN-2 will further
add to a long-standing commitment to Pediatric-focused initiatives across the state. When funded, it will continue
to position us to fully leverage additional funds that support Pediatric research infrastructure and provide access
to cutting edge trials, both of which will positively impact the health of the children of WV.
摘要
西弗吉尼亚州(WV)具有长期的身体,心理和财政特征,包括阿片类药物
危机、有限的资源和受限制的经济严重影响了居民的健康。
西弗吉尼亚州儿科临床试验网络(WVPCTN),作为ECHO IDEA States PCTN的临床研究中心
(ISPCTN)通过履行其使命,促成了解决其中一些负担的新解决方案。
具体来说,WVPCTN的使命是双重的--为我们服务不足的人群带来临床试验,
并建立临床研究的专业能力。我们的西弗吉尼亚大学网站已经被定位为一个成功的
由于ISPCTN时已经到位的结构和人力资源的组合,
于2016年启动,三位PI的背景和专业知识-扫罗博士,Pyles博士和Cottrell博士。的
由于ISPCTN提供的资金和资源的增加,WVU的能力得到了加速,
参与临床试验,允许我们创建一个专门的儿科研究单位(PRU),并引入一个
一组资历较浅、经验较少的临床试验研究者,参与ISPCTN和非ISPCTN试验。的
这种方法的有效性已经通过增加教师参与ISPCTN得到了证明
活动,一个强大的招聘记录,并在非ISPCTN儿科试验在西弗吉尼亚大学的数量增加。
WVPCTN现在正在积极发展一个经验丰富的调查员库和一组学员调查员,
通过西弗吉尼亚临床转化科学研究所(WVCTSI)的资源和专业知识得到加强。
这些特点和资源,加上全州强大和持续的伙伴关系,
我们的公民的多种环境相关的条件,继续独特的定位,我们是成功的,
一个ISPCTN临床站点,并致力于为网络提出新的试验。WVPCTN-2的提案将进一步
增加了对全州儿科重点倡议的长期承诺。一旦获得资金,
使我们能够充分利用额外的资金来支持儿科研究基础设施,
到尖端试验,这两项试验都将对西弗吉尼亚州儿童的健康产生积极影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LESLEY A COTTRELL其他文献
LESLEY A COTTRELL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LESLEY A COTTRELL', 18)}}的其他基金
FOYC+ImPACT US: A digital platform for critical sexual health risk reduction curriculum customization and hybrid/remote delivery of Focus on Youth to underserved Caribbean youth in the U.S.
FOYC ImPACT US:一个数字平台,用于关键的性健康风险降低课程定制以及混合/远程向美国服务不足的加勒比青年提供“关注青年”课程。
- 批准号:
10699553 - 财政年份:2023
- 资助金额:
$ 41.79万 - 项目类别:
West Virginia Pediatric Clinical Trials Network-2
西弗吉尼亚州儿科临床试验 Network-2
- 批准号:
10470164 - 财政年份:2020
- 资助金额:
$ 41.79万 - 项目类别:
West Virginia Pediatric Clinical Trials Network-2
西弗吉尼亚州儿科临床试验 Network-2
- 批准号:
10239228 - 财政年份:2020
- 资助金额:
$ 41.79万 - 项目类别:
The West Virginia Pediatric Clinical Trials Network
西弗吉尼亚州儿科临床试验网络
- 批准号:
9461966 - 财政年份:2016
- 资助金额:
$ 41.79万 - 项目类别:
The West Virginia Pediatric Clinical Trials Network
西弗吉尼亚州儿科临床试验网络
- 批准号:
9263115 - 财政年份:2016
- 资助金额:
$ 41.79万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 41.79万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 41.79万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 41.79万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 41.79万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 41.79万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 41.79万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 41.79万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 41.79万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 41.79万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 41.79万 - 项目类别:
Operating Grants